Results 121 to 130 of about 47,788 (193)

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage, Becky Bishop, Vikki Mangano, Baher Mankabady   +3 more
wiley   +1 more source

Pregnancy in women with mitochondrial disease—A literature review and suggested guidance for preconception and pregnancy care

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 65, Issue 1, Page 30-36, February 2025.
Mitochondrial donation to reduce the risk of primary mitochondrial disease transmission from mother to child is now permitted under Australian law as part of a clinical trial. The energy demands of pregnancy have the potential to worsen mitochondrial disease symptoms and severity in affected women.
Lisa Hui, Pema Hayman, Ali Buckland, Michael C Fahey, David A Mackey, Andrew J Mallett, Daniel R Schweitzer, Clare P Stuart, Wai Yan Yau, John Christodoulou   +9 more
wiley   +1 more source

The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Cannabis use during pregnancy is becoming more prevalent. While numerous studies have explored the relationship of cannabis use during pregnancy and outcomes for mothers and infants, uncertainty remains regarding the impact of cannabis use on pregnancy complications and later‐life outcomes for offspring.
Zachary Munn, Danielle Pollock, Jennifer Stone, Sabira Hasanoff, Andrea Gordon, Carrie Price, Michael Stark, Timothy Hugh Barker   +7 more
wiley   +1 more source

Increasing Use of Antenatal Magnesium Sulphate Prior to Preterm Birth for Preventing Cerebral Palsy in Australia and New Zealand, 2012–2020: A Binational Registry Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT We assessed the use of magnesium sulphate prior to preterm birth for preventing cerebral palsy in an Australian and New Zealand registry study. Use increased markedly from 32.3% (2012) to 78.8% (2020) (p < 0.001). Binational approaches to sustain and explore the feasibility of further increasing use, informed by evolving evidence and ...
Emily Shepherd, Sarah McIntyre, Alice Rumbold, Tasneem Karim, Shona Goldsmith, Amy Keir, Amanda Poprzeczny, Rod W. Hunt, Nadia Badawi, Christopher J. D. Mckinlay, Caroline A. Crowther, Lisa Yelland, the Australian and New Zealand Neonatal Network (ANZNN)   +12 more
wiley   +1 more source

Does Maternal Location of Residence Affect Low Birth Weight Outcomes in Hunter New England Local Health District?

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Low birth weight (LBW) is associated with adverse short‐term and long‐term health outcomes for neonates. The impact of maternal geographical location on rates of LBW in Australia is conflicted in existing literature. Aims The aim was to identify if a difference in rates of LBW exist between neonates born to rural versus metropolitan
Polly R. Britten, Darcy L. McNaughton, Samantha L. Moore, Shelby A. Edwards, Leanne J. Brown, Natasha Weaver, Tracy L. Schumacher   +6 more
wiley   +1 more source

Maternity Healthcare Worker Perspectives of Severe Acute Maternal Morbidity Recording, Reporting and Case Review in Queensland, Australia

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Systematic, multi‐disciplinary review of Severe Acute Maternal Morbidity (SAMM) can improve maternal outcomes. Routinely collected data, collated into the Queensland SAMM Dashboard, may facilitate local case review. We wanted to understand how SAMMs are reviewed locally and how centrally collated data supports review processes ...
Joanne Frost, Edward Weaver, Leonie Callaway   +2 more
wiley   +1 more source

Characteristics and Causes of Stillbirths Following Disruption to Antenatal Care During Implementation of COVID‐19 Mitigation Measures

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background and Aim Restrictions to mitigate COVID‐19 transmission during the pandemic led to the disruption of routine antenatal care. We aimed to assess if those disruptions impacted the rates and types of stillbirths that occurred during that time.
Jasmine Donaghey, Sandy Chu, Shivadharshini Sridhar, Atul Malhotra, Kirsten R. Palmer, Daniel L. Rolnik, Ben W. Mol   +6 more
wiley   +1 more source

Verbal Information From Parents About Stillbirth: The VIPS Study (Phase One)

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background In many countries, a baby's cause of death (COD) following stillbirth is informed only by case notes and pathology investigations. However, parents' understanding of their baby's COD may inform or even change the COD diagnosis.
Azriel Gan Lin Lo, Lauren J. Breen, Zoe Bradfield, Scott White, Sonya Criddle, Georgia Griffin, Bligh Berry, Jane Warland   +7 more
wiley   +1 more source

Knowledge and Awareness of Cardiovascular Risk Factors Among Women With a History of Pregnancy Complications in Australia: A World Heart Federation Cross‐Sectional Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Cardiovascular disease (CVD) is the leading cause of death worldwide, and women who experience complications during pregnancy, such as pregnancy loss (miscarriage and stillbirth), hypertensive disorders of pregnancy and gestational diabetes, have a significantly higher risk of future CVD. Increasing awareness of CVD risk among these
Farnoosh Asghar Vahedi, Leila Gholizadeh, Marjan Khajehei   +2 more
wiley   +1 more source

Proactive Insulin Escalation for Antenatal Betamethasone‐Induced Hyperglycaemia in Women With Diabetes: A Prospective Cohort Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background In patients with diabetes, antenatal glucocorticoids can induce transient maternal hyperglycaemia for approximately 72 h. This may be associated with adverse outcomes, including neonatal hypoglycaemia, prompting recommendations for prophylactic increases in insulin by some expert groups; however, there are no validated protocols.
Annabel Jones, Joanna Y. Gong, I‐Lynn Lee, Dev Kevat, Manjri Raval, Joanne Said, Christopher Yates   +6 more
wiley   +1 more source